Regional microglial activation in the substantia nigra is linked with fatigue in MS

Tarun Singhal1, Steven Cicero2, Hong Pan2

  • 1From the Partners MS Center (T.S., S.C., K.C., B.G., R.B., H.L.W.), Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; PET Imaging Program in Neurologic Diseases (T.S., S.C., K.C.), Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Functional Neuroimaging Laboratory (H.P., R.B., D.S.), Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Division of Nuclear Medicine and Molecular Imaging (S.D., M.-A.P., M.K.), Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Laboratory for Neuroimaging Research (R.C., S.T.), Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Medicine (S.H.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Ceretype Neuromedicine (E.S.)Department of Radiology (R.B.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA. tsinghal@bwh.harvard.edu.

Abstract

Insights

Microglial activation in the substantia nigra is linked to fatigue in multiple sclerosis (MS). This finding suggests neuroinflammation may be a key factor in MS-associated fatigue (MSAF).

Area of Science:

  • Neuroscience
  • Immunology
  • Radiology

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • MS-associated fatigue (MSAF) significantly impacts patient quality of life.
  • The underlying mechanisms of MSAF, particularly the role of neuroinflammation, are not fully understood.

Purpose of the Study:

  • To investigate the association between microglial activation and fatigue in MS patients.
  • To utilize [F-18]PBR06-PET imaging to quantify neuroinflammation.
  • To explore the relationship between specific brain regions and fatigue severity.

Main Methods:

  • 12 MS patients and 10 healthy controls underwent [F-18]PBR06-PET scans.
  • Fatigue severity was assessed using the Modified Fatigue Impact Scale (MFIS).
  • PET data were analyzed using voxel-based and atlas-based methods, coregistered with MRI.

Main Results:

  • A significant correlation was found between microglial activation in the right substantia nigra and total MFIS scores.
  • The right substantia nigra independently predicted total and cognitive MFIS scores.
  • Additional correlations were observed in the parahippocampal gyrus, precuneus, and white matter.

Conclusions:

  • Microglial activation in the substantia nigra is a key factor in MS-associated fatigue.
  • Neuroinflammation in specific brain regions may underlie MSAF.
  • Further research into the neuroimmunological basis of MSAF is warranted.